Tasly Pharma

Tasly Pharma, founded in 1994, is a prominent pharmaceutical manufacturing entity headquartered in Tianjin, China. The company operates within the global healthcare sector, focusing on the research, development, production, and distribution of diverse pharmaceutical solutions. As a publicly traded organization listed on the Shanghai Stock Exchange under the ticker 600535, Tasly Pharma maintains a significant operational footprint across the Asia-Pacific region. The firm leverages its extensive manufacturing capabilities to serve both domestic and international markets, positioning itself as a key player in the pharmaceutical industry.

With a workforce ranging from 5,000-10,000 employees, the company sustains robust operational capacity to support its complex supply chain and product development cycles. Meet Tasly Pharma's team to understand the leadership and technical expertise driving their innovation in pharmaceutical manufacturing. The organization focuses on high-quality production standards, ensuring compliance with international healthcare regulations while expanding its reach in the competitive pharmaceutical landscape. Their commitment to research and development remains a cornerstone of their business strategy, facilitating the delivery of advanced medical solutions to a broad patient base.

Financially, Tasly Pharma reports annual revenue of $1.2B, reflecting its stable market position and consistent growth trajectory within the healthcare sector. The company continues to prioritize strategic investments in its manufacturing infrastructure and product portfolio to maintain its competitive edge. By integrating advanced technology and rigorous quality control, the firm addresses critical healthcare needs across its primary markets. Tasly Pharma remains dedicated to enhancing its operational efficiency and market penetration, leveraging its long-standing history since 1994 to navigate the evolvingView more...